Tenaya Therapeutics, Inc. - 8-K Filing
Tenaya Therapeutics appointed Eric Hyllengren as Chief Financial Officer effective July 13, 2026. Hyllengren will receive an annual base salary of $490,000 and a target bonus of 40% of his base salary. He is also set to receive an option for 1,650,000 shares under the company's equity plan. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure On June 29, 2026, the Company issued a press release announcing Mr, 9.01 Financial Statements and Exhibits)
Tickers: $TNYA